Top compounds associated with response to DYTN


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.033 0.5
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.021 0.5
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.073 0.5
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.5
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.017 0.5
mRNA CMK GDSC1000 pan-cancer AAC -0.032 0.5
mRNA KIN001-244 GDSC1000 pan-cancer AAC 0.018 0.5
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.022 0.5
Download CSV